Picture of Spago Nanomedical AB (publ) logo

SPAGO Spago Nanomedical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Spago Nanomedical: US Patent Granted For Tumorad

June 26 (Reuters) - SPAGO NANOMEDICAL AB (PUBL)  SPAGO.TE :
    * US PATENT GRANTED FOR TUMORAD®
    * UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
GRANTED
COMPANY'S PATENT APPLICATION
    * PATENT, WITH TITLE "NANOSTRUCTURES AND APPLICATIONS
THEREOF"
    * PATENT HAS BEEN ASSIGNED PATENT NUMBER US 9,999,963 AND IS
VALID
UNTIL YEAR 2035

Source text for Eikon:  ID:nWkr8JgZkP 
Further company coverage:  SPAGO.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))

Recent news on Spago Nanomedical AB (publ)

See all news